Iatrogenic cerebral amyloid angiopathy in older adults

Eur J Neurol. 2024 Jun;31(6):e16278. doi: 10.1111/ene.16278. Epub 2024 Mar 21.

Abstract

Background and purpose: An increasing number of cases of iatrogenic cerebral amyloid angiopathy (CAA) have now been reported worldwide. Proposed diagnostic criteria require a history of medical intervention with potential for amyloid-β transmission, for example those using cadaveric dura mater or requiring instrumentation of the brain or spinal cord. Clinical presentation occurs after an appropriate latency (usually three or four decades); to date, most patients with iatrogenic CAA have had 'early-onset' disease (compared to sporadic, age-related, CAA), as a consequence of childhood procedures.

Results: We describe five cases of possible iatrogenic CAA in adults presenting in later life (aged 65 years and older); all had prior neurosurgical interventions and presented after a latency suggestive of iatrogenic disease (range 30-39 years). Use of cadaveric dura mater was confirmed in one case, and highly likely in the remainder.

Conclusion: The presentation of iatrogenic CAA in older adults widens the known potential spectrum of this disease and highlights the difficulties of making the diagnosis in this age group, and particularly in differentiating iatrogenic from sporadic CAA. Increased vigilance for cases presenting at an older age is essential for furthering our understanding of the clinical phenotype and broader implications of iatrogenic CAA.

Keywords: amyloid‐β; cadaveric dura mater; iatrogenic cerebral amyloid angiopathy; neurosurgery; prion.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cerebral Amyloid Angiopathy* / complications
  • Female
  • Humans
  • Iatrogenic Disease*
  • Male